Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10930 | 955 | 47.4 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DORSAL SKINFOLD CHAMBER | Author keyword | 7 | 35% | 2% | 16 |
2 | ABORAT PARTNER LARGE BONE DEFECT HEALING | Address | 6 | 100% | 0% | 4 |
3 | INOSCULATION | Author keyword | 5 | 54% | 1% | 7 |
4 | ABORAT AO FDN | Address | 5 | 63% | 1% | 5 |
5 | BONE REPAIR | Address | 5 | 63% | 1% | 5 |
6 | FREIBURG MAT MACROMOL CHEM | Address | 4 | 75% | 0% | 3 |
7 | MICROVASCULAR FRAGMENTS | Author keyword | 3 | 100% | 0% | 3 |
8 | VIP SERV | Address | 3 | 60% | 0% | 3 |
9 | PERIOSTEAL DERIVED CELLS | Author keyword | 2 | 44% | 0% | 4 |
10 | REPAIR | Address | 2 | 16% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN OSTEOPROGENITORS | 38 | 84% | 2% | 21 |
2 | SPHEROIDAL COCULTURE MODEL | 33 | 83% | 2% | 19 |
3 | MICROVESSEL LIKE STRUCTURES | 17 | 100% | 1% | 8 |
4 | MICROVESSEL FRAGMENTS | 15 | 82% | 1% | 9 |
5 | EPIPHYSIAL CARTILAGE | 9 | 83% | 1% | 5 |
6 | SIZE DEFECT MODEL | 8 | 41% | 2% | 16 |
7 | DUAL DELIVERY | 7 | 39% | 1% | 14 |
8 | INOSCULATION | 7 | 67% | 1% | 6 |
9 | TROPHIC FACTOR SECRETION | 6 | 100% | 0% | 4 |
10 | CAPILLARY LIKE NETWORK | 5 | 54% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Review of vascularised bone tissue-engineering strategies with a focus on co-culture systems | 2015 | 7 | 165 | 27% |
Vascularization in Bone Tissue Engineering: Physiology, Current Strategies, Major Hurdles and Future Challenges | 2010 | 116 | 183 | 33% |
Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering | 2009 | 83 | 66 | 64% |
Distinct VEGF Functions During Bone Development and Homeostasis | 2014 | 7 | 43 | 40% |
VEGF and bone cell signalling: an essential vessel for communication? | 2013 | 23 | 104 | 34% |
Vascularization is the key challenge in tissue engineering | 2011 | 170 | 160 | 14% |
Osteogenesis and angiogenesis: The potential for engineering bone | 2008 | 278 | 159 | 24% |
The Pivotal Role of Vascularization in Tissue Engineering | 2013 | 37 | 125 | 18% |
Role of angiogenesis in bone repair | 2014 | 5 | 207 | 35% |
Vascularization in Tissue Engineering: Angiogenesis versus Inosculation | 2012 | 19 | 73 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABORAT PARTNER LARGE BONE DEFECT HEALING | 6 | 100% | 0.4% | 4 |
2 | ABORAT AO FDN | 5 | 63% | 0.5% | 5 |
3 | BONE REPAIR | 5 | 63% | 0.5% | 5 |
4 | FREIBURG MAT MACROMOL CHEM | 4 | 75% | 0.3% | 3 |
5 | VIP SERV | 3 | 60% | 0.3% | 3 |
6 | REPAIR | 2 | 16% | 1.4% | 13 |
7 | UMR S577 | 2 | 43% | 0.3% | 3 |
8 | ORAL BIOENGN REGENERAT MED | 1 | 38% | 0.3% | 3 |
9 | BIOMED BK21 MED | 1 | 100% | 0.2% | 2 |
10 | MICROVASC SURG VASC TISSUE ENGN | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000235084 | ARTERIOVENOUS LOOP//AV LOOP//AXIAL VASCULARIZATION |
2 | 0.0000152477 | SKELETAL BIOTECH//FACILITATED ENDOGENOUS REPAIR//SKELETAL BIOTECHNOL |
3 | 0.0000116419 | AQUITAINE LIMOUSIN BRANCH//BIOTHER Y HUMAN OURCES BK 21//PEDIAT SURG CHILDRENS SURG PROGRAM |
4 | 0.0000104828 | LONGEV SCI//HOSP GERIATR MED//TORAT MED |
5 | 0.0000101211 | FLOW PERFUSION//FLOW PERFUSION BIOREACTOR//PERFUSION BIOREACTOR |
6 | 0.0000100797 | DELTA LIKE LIGAND 4//DLL4//ARTERIAL VENOUS DIFFERENTIATION |
7 | 0.0000095020 | FRACTURE HEALING//TISSUE DIFFERENTIATION//INTERFRAGMENTARY MOVEMENT |
8 | 0.0000092856 | PERICYTES//PERICYTE//BOVINE RETINAL PERICYTES |
9 | 0.0000091936 | GROWTH HORMONE BIOL//IN SITU SETTING CEMENT//POLYD L LACTIDE COATING |
10 | 0.0000086629 | AQUAMIN//STRAND FARM//MINERALIZED SCAFFOLDS |